Clearbridge partners Australia's Genome.One for personal health genomics programme

Clearbridge partners Australia's Genome.One for personal health genomics programme

Michelle Zhu
26/06/18, 06:17 pm

SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Genome.One GoExplore personal health genomics programme.

The programme sequences and analyses individual DNA samples assess their risk of developing 52 hereditary conditions, including 31 cancers, 13 heart conditions, as well as several other conditions where monitoring or intervention can be of benefit.

The test will also determine patients’ likely response to over 220 different types of medication.

Under the partnership, Clearbridge clinicians will refer patients in Singapore and Hong Kong to the programme.

On the other hand, Genome.One’s genetic health professionals will provide pre- and post-testing support to these individuals via telehealth consultations, with interpreters and different language reports also available for non-English speaking patients.

In a Tuesday release, Clearbridge says its partnership with Genome.One is strongly in line with the group’s focus on the delivery of clinical-grade precision medicine by enabling healthcare professionals to gain better insights into management of hereditary conditions.

This is a ground-breaking test that will allow patients to understand their risk level in terms of hereditary conditions by analysing one’s unique genomic information and how the human body will react to a host of different medications, we are then able to provide customised and targeted preventive treatments for our patients,” comments Jeremy Yee, executive director and CEO of Clearbridge, on the Genome.One GoExplore programme.

“This partnership reinforces our commitment as a leading precision healthcare provider, to offer individualised and holistic solutions for future healthcare management,” he adds.

Shares in Clearbridge closed 1.4% higher at 36 cents on Tuesday.

Najib arrested for alleged tampering of 1MDB report

SINGAPORE (Dec 10): Malaysia’s ex-prime minister, Najib Razak, has been arrested yet again by the Malaysian Anti-Corruption Commission (MACC). But this time, over the “tampering” of the 1Malaysia Development Berhad (1MDB) final audit report. Najib arrived at the MACC headquarters earlier today at 10.40am, apparently to assist in investigations regarding the above allegations. He was later arrested at about 11.00am. At around 1.20pm, Najib was released after posting bail. MACC is believed to charge Najib and former 1MDB president Arul Kanda this Wednesday over the alleged tamperi....

Singapore authorities block New Noble listing

SINGAPORE (Dec 10): The Monetary Authority of Singapore (MAS) and Singapore Exchange Regulation (SGX RegCo) have barred Noble Group from transferring its listing status to New Noble as part of its restructuring process. This comes after a “careful review” of the findings to-date from the ongoing investigations into the commodities trader and its Singapore-incorporated subsidiary Noble Resources International (NRI). According to a joint statement by MAS, the Commercial Affairs Department (CAD) and SGX RegCo, the decision to block the New Noble listing arose from doubts about New Noble’....

Balancing profit and motive

SINGAPORE (Dec 10): On Dec 5, the UK government published a trove of internal Facebook emails and other documents that suggested the social media platform sought to trade users’ data with advertisers, or wield it for strategic advantage with third-party applications. Facebook has been under increasing scrutiny amid privacy concerns, and the backlash to the news was to be expected. In its defence, Facebook said it was seeking a way to ensure the sustainability of its business. As a business, Facebook should indeed be looking for the best way to monetise or leverage its assets — users’ ....
Active management can deliver attractive returns amid tightening liquidity, says Charles Schwab

SINGAPORE (Dec 10): In the last few years, passive fund management has become increasingly popular a